Glucocorticoid receptor and molecular chaperones in the pathogenesis of adrenal incidentalomas: Potential role of reduced sensitivity to glucocorticoids

Molecular Medicine

Volumn 18, Issue 11, 2012, Pages 1456-1465

  Damjanovic, Svetozar S ^a   Antic, Jadranka A ^a   Ilic, Bojana B ^a   Cokic, Bojana Beleslin ^a   Ivovic, Miomira ^a   Ognjanovic, Sanja I ^a   Isailovic, Tatjana V ^a   Popovic, Bojana M ^a   Bozic, Ivana B ^a   Tatic, Svetislav ^a   Matic, Gordana ^a   Todorovic, Vera N ^b   Paunovic, Ivan ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY BUSINESS ACADEMY   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; CORTICOTROPIN RECEPTOR; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HYDROCORTISONE;

ADRENAL CORTEX ADENOMA; ADRENAL INCIDENTALOMA; ADRENOCORTICOTROPIN RECEPTOR GENE; ADULT; AGED; ARTICLE; CARCINOGENESIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLUCOCORTICOID RECEPTOR GENE; HEAT SHOCK PROTEIN GENE; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; TISSUE DISTRIBUTION; TUMOR VOLUME; WAIST CIRCUMFERENCE; WESTERN BLOTTING;

ADRENAL CORTEX; ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL EXTRACTS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCOCORTICOIDS; HAPLOTYPES; HEAT-SHOCK PROTEINS; HUMANS; INTRACELLULAR SPACE; MALE; MIDDLE AGED; MOLECULAR CHAPERONES; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CORTICOTROPIN; RECEPTORS, GLUCOCORTICOID; RISK FACTORS; SUBCELLULAR FRACTIONS;

EID: 84872402518     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2012.00261     Document Type: Article

References (55)

1. Angeli A, Osella G, Ali A, Terzolo M. (1997) Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. Horm. Res. 47:279-83.
2. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. (1995) Incidentally discovered adrenal masses. Endocr. Rev. 16:460-84.
3. Mansmann G, et al. (2004) The clinically inapparent adrenal mass: update in diagnosis and management. Endocr. Rev. 25:309-40.
4. Dackiw APB, Lee JE, Gagel RF, Evans DB. (2001) Adrenal cortical carcinoma. World J. Surg. 25:914-26.
5. McLeod M, Thomuson N, Gross M, Bondeson A, Bondeson L. (1990) Sub-clinical Gushing's syndrome in patients with adrenal gland incidentalomas: pitfalls in diagnosis and management. Am. Surgeon. 56:398-403.
6. Rossi R, et al. (2000) Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J. Clin. Endocrinol. Metab. 85:1440-8.
7. Terzolo M, et al. (2005) Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma. Eur. J. Endocrinol. 153:307-15.
8. Huizenga NATM, et al. (1998) A polymorphism in the glucocorticoid receptor gene may be associated with an increased sensitivity to glucocorticoids in vivo. J. Clin. Endocrinol. Metab. 83:144-51.
9. Gummow BM, Scheys JO, Cancelli VR, Hammer GD. (2006) Reciprocal regulation of a glucocorticoid receptor-steroidogenic factor-1 transcription complex on the Dax-1 promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex. Mol. Endocrinol. 20:2711-23.
10. Sanchez ER. (1992) Heat shock induces translocation to the nucleus of the unliganded glucocorticoid receptor. J. Biol. Chem. 267:17-20.
11. Shen P, Xie Z-J, Li H, Sanchez ER. (1993) Glucocorticoid receptor conversion to high affinity nuclear binding and transcription enhancement activity in Chinese hamster ovary cells subjected to heat and chemical stress. J. Steroid. Biochem. Mol. Biol. 47:55-64.
12. Liu W, Hillmann AG, Harmon JM. (1995) Hormone-independent repression of the AP-1-inducible collagenase promoter activity by glucocorticoid receptors. Mol. Cell. Biol. 15:1005-13.
13. Sivo J, Harmon JM, Vogel SN. (1996) Heat shock mimics glucocorticoid effects on IFN-m-induced Fc FFRI and Ia messenger RNA expression in mouse peritoneal macrophages. J. Immunol. 156:3450-4.
14. Bourdeau I, et al. (2003) Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor. J. Clin. Endocrinol. Metab. 88:3931-7.
15. Boyle B, et al. (2010) Expression of glucocorticoid receptor isoforms in human adrenocortical adenomas. Steroids. 75:695-700.
16. Matthews DR, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in men. Diabetologia. 28:412-9.
17. Stephens M, Smith NJ, Donnelly P. (2001) A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68:978-89.
18. Fleury I, et al. (2003) Characterisation of the BclI polymorphism in the glucocorticoid receptor gene. Clin. Chem. 49:1528-31.
19. Murray JC, Smith RF, Ardinger HA, Weinberger C. (1987) RFLP for the glucocorticoid receptor (GRL) located at 5q11-5q13. Nucl. Acids Res. 15:6765.
20. Rosmond R, Dallman MF, Bjorntorp P. (1998) Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J. Clin. Endocrinol. Metab. 83:1853-9.
21. Bjorntorp P, Holm G, Rosmond R. (1999) Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabet. Med. 16:373-83.
22. Tomlinson JW, et al. (2004) 11(-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr. Rev. 25:831-66.
23. Peppa M, Maria Krania M, Raptis SA. (2011) Hypertension and other morbidities with Cushing's syndrome associated with corticosteroids: a review. Integr. Blood Press. Control. 4:7-16.
24. van Rossum EFC, et al. (2003) Identification of BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index. Clin. Endocrinol. 59:585-92.
25. Weaver JU, Hitman GA, Kopelman PG. (1992) An association between a Bcl1 restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women. J. Mol. Endocrinol. 9:295-300.
26. Rosmond R, et al. (2000) A polymorphism of the 50-flanking region of the glucocorticoid receptor gene locus is associated with basal cortisol secretion in men. Metabolism. 49:1197-9.
27. Buemann B, et al. (1997) Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes. Res. 5:186-92.
28. Di Blasio AM, et al. (2003) The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients. Clin. Endocrinol. 59:68-74.
29. Szappanos Á, et al. (2009) BclI polymorphism of the glucocorticoid receptor gene is associated with decreased bone mineral density in patients with endogenous hypercortisolism. Clin. Endocrinol. 71:636-43.
30. Morelli V, et al. (2010) Role of glucocorticoid receptor polymorphism in adrenal incidentalomas. Eur. J. Clin. Invest. 40:803-11.
31. Syed AA, et al. (2006) Association of glucocorticoid receptor polymorphism A3669G in exon 9beta with reduced central adiposity in women. Obesity (Silver Spring). 14:759-64.
32. Trementino L, et al. (2012) Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome. Eur. J. Endocrinol. 166:35-42.
33. Schaaf MJ, Cidlowski JA. (2002) AUUUA motifs in the 3tUTR of human glucocorticoid receptor alpha and beta mRNA destabilize mRNA and decrease receptor protein expression. Steroids. 67:627-36.
34. Panarelli M, et al. (1996) Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J. Clin. Endocrinol. Metab. 83:1846-52.
35. van Rossum EF, et al. (2004) The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults. J. Clin. Endocrinol. Metab. 89:4004-9.
36. Nick Z, Lu NZ, Cidlowski JA. (2005) Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol. Cell. 18:331-42.
37. Duma D, Jewell CM, Cidlowski JA. (2006) Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J. Steroid. Biochem. Mol. Biol. 102:11-21.
38. Chrousos GP, Kino T. (2005) Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci. STKE. 2005:pe48.
39. Graybeal ML, Fang VS, Landau RI. (1985) Enhancement of adrenal cortisol secretion after intravenous high dose dexamethasone. J. Clin. Endocrinol. Metab. 61:607-11.
40. Wu GJ, et al. (2011) Effects of propofol on proliferation and anti-apoptosis of neuroblastoma SHSY5Y cell line: new insights into neuroprotection. Brain Res. 1384:42-50.
41. Wadekar SA, Li D, Periyasamy S, Sánchez ER. (2001) Inhibition of heat shock transcription factor by GR. Mol. Endocrinol. 15:1396-410.
42. Cochet C, Job D, Dhien A, Chambaz EM. (1977) A soluble glucocorticoid binding protein in the bovine adrenal cortex. Arch. Biochem. Biophys. 180:1-9.
43. Loose DS, Do YS, Chen TL, Feldman D. (1980) Demonstration of glucocorticoid receptors in the adrenal cortex: evidence for a direct dexamethasone suppressive effect on the rat adrenal gland. Endocrinology. 107:137-46.
44. Yang K, Challis JR. (1989) Fetal and adult sheep adrenal cortical cells contain glucocorticoid receptors. Biochem. Biophys. Res. Commun. 162:604-11.
45. Root B, Abrassart J, Myers DA, Monau T, Ducsay CA. (2008) Expression and distribution of glucocorticoid receptors in the ovine fetal adrenal cortex: effect of long-term hypoxia. Reprod. Sci. 15:517-28.
46. Jiang X, Wang J, Luo T, Li Q. (2009) Impaired hypothalamic-pituitary-adrenal axis and its feedback regulation in serotonin transporter knockout mice. Psychoneuroendocrinology. 34:317-31.
47. Paust HJ, et al. (2006) Expression of the glucocorticoid receptor in the human adrenal cortex. Exp. Clin. Endocrinol. Diabetes. 114:6-10.
48. Kontula K, Pomoell UM, Gunsalus GL, Pelkonen R. (1985) Glucocorticoid receptors and responsiveness of normal and neoplastic human adrenal cortex. J. Clin. Endocrinol. Metab. 60:283-9.
49. Bouligand J, et al. (2010) Familial glucocorticoid receptor haploinsufficiency by non-sense mediated mRNA decay, adrenal hyperplasia and apparent mineralocorticoid excess. PLoS One. 5:e13563.
50. Tacon LJ, et al. (2009) The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors. J. Clin. Endocrinol. Metab. 94:4591-9.
51. Vanderbilt JN, Miesfeld R, Maler BA, Yamamoto KR. (1987) Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol. Endocrinol.1:68-74.
52. Kojika S, et al. (1996) Mechanisms of glucocorticoid resistance in human leukemic cells: implication of abnormal 90 and 70 kDa heat shock proteins. Leukemia. 10:994-9.
53. Tsagarakis S, et al. (1998) The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome. Clin. Endocrinol. 48:627-33.
54. Bernini GP, et al. (2002) Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues. Br. J. Cancer. 86:1561-5.
55. Gross KL, Okley RH, Scoltock AB, Jewell CM, Cidlowski JA. (2011) Glucocorticoid receptor C isoform-selective regulation of antiapoptotic genes in osteosarcoma cells: a new mechanism for glucocorticoid resistance. Mol. Endocrinol. 25:1087-99.